Differential roles of telomere attrition in type I and II endometrial carcinogenesis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Pathology

• Publication date

  2008-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2353/ajpath.2008.071179PMID 18599611PMCID PMC2475790
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An Oncogene-Induced DNA Damage Model for Cancer Development

  2008cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma.

  2006cited by this paper
• Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.

  2006cited by this paper
• Pathologic features of endometrial carcinoma associated with HNPCC

  2006cited by this paper
• Molecular and pathologic aspects of endometrial carcinogenesis.

  2006cited by this paper
• Shelterin: the protein complex that shapes and safeguards human telomeres.

  2005cited by this paper
• BCL-2 and P53 expression in endometrial carcinoma.

  2004cited by this paper
• Non-Endometrioid Carcinomas of the Uterine Corpus: A Review of Their Pathology With Emphasis on Recent Advances and Problematic Aspects

  2004cited by this paper
• Focus on endometrial and cervical cancer.

  2004cited by this paper
• Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma.

  2004cited by this paper
• Genomic aberrations in carcinomas of the uterine corpus

  2004cited by this paper
• Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

  2004cited by this paper
• Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis

  2004cited by this paper
• The age of cancer: telomeres, checkpoints, and longevity.

  2003cited by this paper
• Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers

  2003cited by this paper
• Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses

  2003cited by this paper
• Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia.

  2002cited by this paper
• Chromosomal instability in ulcerative colitis is related to telomere shortening

  2002cited by this paper
• Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis.

  2002cited by this paper
• Establishment and characterization of a poorly differentiated lethal human endometrial carcinoma cell line (NOU-1) with karyotype 46,XX.

  2002cited by this paper
• Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining.

  2002cited by this paper
• Endometrioid Carcinoma of the Uterine Corpus: A Review of Its Pathology With Emphasis on Recent Advances and Problematic Aspects

  2002cited by this paper
• Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium.

  2002cited by this paper
• Is the telomerase assay useful for screening of endometrial lesions?

  2002cited by this paper
• DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice.

  2002cited by this paper
• The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability.

  2001cited by this paper
• A prospective, randomized study of endometrial telomerase during the menstrual cycle.

  2001cited by this paper
• Telomerase and cancer: where and when?

  2001cited by this paper
• The Hallmarks of Cancer Review

  2000cited by this paper
• Telomere length in different tissues of elderly patients.

  2000cited by this paper
• Mutational Analysis of the CTNNB1 and APC Genes in Uterine Endometrioid Carcinoma

  2000cited by this paper
• Wild-derived inbred mouse strains have short telomeres.

  2000cited by this paper
• A critical role for telomeres in suppressing and facilitating carcinogenesis.

  2000cited by this paper
• Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice

  2000cited by this paper
• The frequency of p53, k‐ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma

  2000cited by this paper
• International Society of Gynecological Pathologists Symposium on Endometrial Hyperplasia II. The Molecular Biology of Endometrial Tumorigenesis: Does It Have a Message?*

  2000cited by this paper
• Longevity, stress response, and cancer in aging telomerase-deficient mice.

  1999cited by this paper
• Chromosome abnormalities in ovarian adenocarcinoma: I. nonrandom chromosome abnormalities from 244 cases

  1999cited by this paper
• p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.

  1999cited by this paper
• Estrogen activates telomerase.

  1999cited by this paper
• Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues

  1999cited by this paper
• A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.

  1997cited by this paper
• Comparison of benign and malignant endometrial lesions for their p53 state, using immunohistochemistry and temperature-gradient gel electrophoresis

  1996cited by this paper
• [Establishment and characterization of the new cell line (EI) from a human endometrial adenocarcinoma].

  1995cited by this paper
• Near-diploid karyotypes with recurrent chromosome abnormalities characterize early-stage endometrial cancer.

  1995cited by this paper
• Evaluation of DNA ploidy in endometrial cancer.

  1993cited by this paper
• The p53-mdm-2 autoregulatory feedback loop.

  1993cited by this paper
• p53 gene mutations in human endometrial carcinoma

  1992cited by this paper
• Two pathogenetic types of endometrial carcinoma.

  1983cited by this paper
• Establishment of a cell line of human endometrial adenocarcinoma in vitro.

  1972cited by this paper

• The Effect of Telomerase Enzyme on Cell Aging and Cancer Formation-Treatment

  2024cites this paper
• Chromogenic detection of telomere lengths in situ aids the identification of precancerous lesions in the prostate

  2023cites this paper
• Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies

  2022cites this paper
• Review of Mendelian Randomization Studies on Endometrial Cancer

  2022cites this paper
• Two-Way Development of the Genetic Model for Endometrial Tumorigenesis in Mice: Current and Future Perspectives

  2021cites this paper
• Female Reproductive System

  2021cites this paper
• PI3K Pathway Effectors pAKT and FOXO1 as Novel Markers of Endometrioid Intraepithelial Neoplasia

  2019cites this paper
• A patient tumour-on-a-chip system for personalised investigation of radiotherapy based treatment regimens

  2019cites this paper
• Telomerase and Telomeres in Endometrial Cancer

  2019cites this paper
• Endometrial Cancer: From Biological to Clinical Approaches

  2019cites this paper
• Implications of telomeres and telomerase in endometrial pathology

  2016cites this paper
• Human endometrial epithelial telomerase is important for epithelial proliferation and glandular formation with potential implications in endometriosis.

  2015cites this paper
• The Functional Interplay Between the t(9;22)-Associated Fusion Proteins BCR/ABL and ABL/BCR in Philadelphia Chromosome-Positive Acute Lymphatic Leukemia

  2015cites this paper
• LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment.

  2015cites this paper
• Three‐dimensional nuclear telomere architecture changes during endometrial carcinoma development

  2013cites this paper
• Telomeres and human reproduction.

  2013cites this paper
• Cooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesis

  2012cites this paper
• Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma.

  2011cites this paper
• Telomeraz Enziminin Tanı ve Tedavide Kullanım Alanı

  2011cites this paper
• Co-regulatory expression quantitative trait loci mapping: method and application to endometrial cancer

  2011cites this paper
• Telomere length and genetic analyses in population‐based studies of endometrial cancer risk

  2010cites this paper
• Mouse models of uterine corpus tumors: clinical significance and utility.

  2010cites this paper
• Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy

  2010cites this paper
• Genetics of Endometrial Cancers

  2010influential citation
• Shortened Telomeres in Serous Tubal Intraepithelial Carcinoma: An Early Event in Ovarian High-grade Serous Carcinogenesis

  2010cites this paper
• Insights into endometrial serous carcinogenesis and progression.

  2009cites this paper
• Causes and consequences of genomic instability in prostatic carcinogenesis.

  2009cites this paper
• Review Article Insights into Endometrial Serous Carcinogenesis and Progression

  2009cites this paper
• Telomere attrition in cancer cells and telomere length in tumor stroma cells predict chromosome instability in esophageal squamous cell carcinoma: a genome-wide analysis.

  2009cites this paper